Hamilton Lane Incorporated HLNE | NASDAQ

$150.68 -$0.72 | -0.48%

After Hours
$149.51 -$1.17 | -0.78%

Next Earnings: Feb 04, 2025

Company Overview:

Market Cap: $8.35B
PE Ratio: 32.61
52-Week Range: $103.424 - $203.72
Dividend Yield (FWD): 1.30% ($1.96)

5.9 Year Performance Metrics:

Total Return (with DRIP): 361.55% (29.59% / yr)
Total Return (no DRIP): 338.39% (28.47% / yr)
Share Price: 315.44%
Dividend Increase: 130.59%
HLNE 5.9-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

HLNE Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
HLNE Dividend CAGR:1Y: 10.11%2Y: 10.68%5Y: 12.25%10Y: N/A
Share Price
HLNE Price CAGR:1Y: 37.61%2Y: 50.37%5Y: 19.80%10Y: 15.31%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

HLNE Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - HLNE
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - HLNE
14-Day FREE Trial Get Full Access Now!

HLNE Earnings, Revenue, Cash & Debt, Shares Outstaning:

HLNE - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
HLNE - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
HLNE - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
HLNE - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
HLNE - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
HLNE - Cash & Debt
14-Day FREE Trial Get Full Access Now!
HLNE - Revenue
14-Day FREE Trial Get Full Access Now!
HLNE Revenue CAGR:1Y: 18.22%2Y: -1.11%5Y: 18.46%10Y: N/A
HLNE - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
HLNE EPS CAGR:1Y: -9.01%2Y: -2.84%5Y: 12.52%10Y: N/A
HLNE - Net Income
14-Day FREE Trial Get Full Access Now!
HLNE Net Income CAGR:1Y: 30.93%2Y: -2.42%5Y: 29.16%10Y: N/A
HLNE - EBITDA
14-Day FREE Trial Get Full Access Now!
HLNE EBITDA CAGR:1Y: 6,862.55%2Y: 3.20%5Y: 17.62%10Y: N/A
HLNE - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
HLNE Free Cash Flow CAGR:1Y: 46.81%2Y: 7.95%5Y: 27.74%10Y: N/A
HLNE - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
HLNE Free Cash Flow / Share CAGR:1Y: 39.50%2Y: 25.61%5Y: 18.47%10Y: N/A
HLNE - Gross Profit
14-Day FREE Trial Get Full Access Now!
HLNE Gross Profit CAGR:1Y: 15.50%2Y: 0.25%5Y: 17.96%10Y: N/A
HLNE - Expenses
14-Day FREE Trial Get Full Access Now!
HLNE Expenses CAGR:1Y: 152.09%2Y: 98.08%5Y: 36.24%10Y: N/A
HLNE - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
HLNE Shares Outstanding CAGR:1Y: 0.44%2Y: 0.40%5Y: 14.42%10Y: N/A
HLNE - Share Buybacks
14-Day FREE Trial Get Full Access Now!
HLNE Share Buybacks CAGR:1Y: -26.37%2Y: 105.04%5Y: 67.11%10Y: N/A
HLNE - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
HLNE Stock-Based Comp CAGR:1Y: 49.92%2Y: 49.71%5Y: 21.62%10Y: N/A
HLNE - Dividends
14-Day FREE Trial Get Full Access Now!
HLNE Dividend CAGR:1Y: 10.11%2Y: 10.68%5Y: 12.25%10Y: N/A
HLNE - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
HLNE Revenue CAGR:1Y: 18.22%2Y: -1.11%5Y: 18.46%10Y: N/A

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

HLNE - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HLNE Actual Revenue CAGR:1Y: 18.22%2Y: -1.11%5Y: 18.46%10Y: N/A
HLNE - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HLNE Actual EPS CAGR:1Y: -9.01%2Y: -2.84%5Y: 12.52%10Y: N/A
HLNE - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HLNE Actual Net Income CAGR:1Y: 30.93%2Y: -2.42%5Y: 29.16%10Y: N/A
HLNE - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HLNE Actual EBITDA CAGR:1Y: 6,862.55%2Y: 3.20%5Y: 17.62%10Y: N/A

Ratios, Profit Margins & Return on Capital:

HLNE - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
HLNE Net Profit Margin CAGR:1Y: 10.73%2Y: -1.32%5Y: 9.02%10Y: N/A
HLNE - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
HLNE Gross Profit Margin CAGR:1Y: -2.30%2Y: 1.38%5Y: -0.43%10Y: N/A
HLNE - Price to Earnings
14-Day FREE Trial Get Full Access Now!
HLNE - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
HLNE - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
HLNE - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

HLNE Dividends Info:

Annual Dividend: $1.96
Forward Yield: 1.3%
Ex-Dividend Date: 2024-12-16
Lifetime Dividens / Share: $10.15

HLNE Dividend History: Dates, Payments & Yield list

Below is a schedule of all HLNE dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
12/16/202401/07/2025$0.4901.14%1.17%$167.52
09/16/202410/04/2024$0.4901.22%1.28%$153.23
06/14/202407/05/2024$0.4901.57%1.69%$116.22
03/14/202404/04/2024$0.4451.67%1.67%$106.30
12/14/202301/05/2024$0.4451.59%1.63%$109.40
09/14/202310/05/2023$0.4451.85%1.95%$91.17
06/14/202307/07/2023$0.4452.14%2.32%$76.85
03/14/202304/06/2023$0.4002.44%2.44%$65.63
12/14/202201/06/2023$0.4002.16%2.23%$71.80
09/14/202210/06/2022$0.4002.12%2.26%$70.76
06/14/202207/07/2022$0.4002.34%2.58%$62.00
03/14/202204/06/2022$0.3501.91%1.91%$73.40
12/14/202101/06/2022$0.3501.32%1.36%$103.26
09/14/202110/06/2021$0.3501.55%1.63%$85.68
06/14/202107/07/2021$0.3501.43%1.55%$90.12
03/12/202104/06/2021$0.3131.44%1.44%$87.10
12/14/202001/07/2021$0.3131.66%1.71%$73.01
09/14/202010/06/2020$0.3131.92%2.05%$61.10
06/12/202007/07/2020$0.3131.81%1.99%$62.69
03/13/202004/06/2020$0.2751.89%1.89%$58.26
12/13/201901/07/2020$0.2751.8%1.91%$57.58
09/13/201910/04/2019$0.2751.61%1.82%$60.49
06/13/201907/05/2019$0.2751.74%2.1%$52.50
03/14/201904/04/2019$0.2131.99%1.99%$42.64
12/13/201801/07/2019$0.2130%0%$0.00
09/13/201810/04/2018$0.2130%0%$0.00
06/15/201807/06/2018$0.2130%0%$0.00
03/14/201804/05/2018$0.1750%0%$0.00
12/14/201701/05/2018$0.1750%0%$0.00
09/14/201710/02/2017$0.1750%0%$0.00
06/22/201707/10/2017$0.1750%0%$0.00

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for HLNE

Based on past 5.9-year performance, here are HLNE growth metrics:

Share price CAGR of +19.8%
Dividend CAGR of +10.84%
Using HLNE CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

HLNE
Current Price$150.68
Start Shares66.37
Start Value$10,000
 
After 10 years:
Final Share Count72.90
Dividends Payment$1.37
Annual Dividends$400
Yield on cost4.00%
Share Price$765.71
Total Dividends$2,292
Final Value$55,820

Estimated Future Value + Dividends - HLNE

NOTE: Above numbers are our estimate based on HLNE's Dividend and Price CAGR over past 5.9 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Hamilton Lane Incorporated (HLNE) had its IPO on 2017-03-01, and is trader on NASDAQ stock exchange.

Hamilton Lane Incorporated is an investment firm specializing in direct and fund of fund investments. It provides following services: separate accounts (customized to each individual client and structured as single client vehicles); specialized strategies (fund-of-funds, secondaries, co-investments, taft-hartley, distribution management); advisory relationships (including due diligence, strategic portfolio planning, monitoring and reporting services); and reporting and analytics solutions. For direct investments, the firm invests in early, mid and late venture, mature companies, growth equity, emerging growth, distressed debt, later stage, turnarounds, bridge financing, mezzanine financing, and buyouts in middle market companies. For fund of fund investments, it invests in mezzanine, venture capital, private equity, turnaround, secondary investments, real estate, and special situation funds. The firm invests in real estate investments. It also invest in technology, healthcare, education, natural resources, energy and essential consumer goods sectors, cleantech, and environment, community development, and financial empowerment. It invests in private equity markets in North America, Latin America, United States, Western Europe, Middle East, Africa, United Kingdom, Asia, Japan, and Australia. The firm prefer to invest $1 million to $100 million in companies. It prefers to have majority stake in companies. Hamilton Lane Incorporated was founded in 1991 and is based in Conshohocken, Pennsylvania with additional offices across Europe, North America, and Asia.

HLNE website: https://www.hamiltonlane.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial